The implementation of a smartphone-based weekly communication and feedback platform between the interdisciplinary diabetes-in-pregnancy clinic team and patients with gestational diabetes mellitus enhanced glycemic control and patient compliance while reducing the need for insulin administration. The gene discussed is INS; the disease is gestational diabetes.